Selegiline

Mechanism #

Monoamine oxidase inhibition; selectivity depends on exposure.

Clinical distinction #

Retrieved oral Parkinson’s-disease label cannot establish antidepressant-patch dosing.

Monitoring and warnings #

Separate patch-specific dietary precautions, interacting drugs and washout evidence.

Formulation scope #

Oral capsule and antidepressant transdermal patch must remain separate.

Dose reference #

A verified formulation-specific dose table is not yet available for this profile. Follow the selected product information; no regimen is inferred from catalogue strengths.

Special populations & counseling #

Age, renal and hepatic function, pregnancy, breastfeeding, co-medication and the treatment indication require medicine-specific review. A general class statement cannot establish suitability for an individual.

Discuss the intended benefit, expected review plan, relevant adverse effects, driving or falls considerations, and how to obtain help. Stopping, switching or restarting requires the exact product’s instructions and clinical assessment.

Brands & products #

Reference coverage #

Ingredient profiles and product records are separate. Details not supplied in this reference must be checked in the exact product information; missing information is not evidence of absence or safety.